Good that there were no SAE.
Bummer that there were no early self-reports of improvement but later tests might show disease modifying effects. Just have to wait.
- Forums
- ASX - By Stock
- PYC
- Ann: RP11 Drug Candidate Safe and Well Tolerated
PYC
pyc therapeutics limited
Add to My Watchlist
1.54%
!
$1.28

Ann: RP11 Drug Candidate Safe and Well Tolerated, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.020(1.54%) |
Mkt cap ! $743.6M |
Open | High | Low | Value | Volume |
$1.31 | $1.31 | $1.28 | $2.370M | 1.830M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3623 | $1.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.28 | 22500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1590 | 1.275 |
1 | 1 | 1.270 |
2 | 424 | 1.265 |
1 | 3982 | 1.260 |
1 | 700 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.290 | 4429 | 3 |
1.295 | 8762 | 2 |
1.300 | 1683 | 2 |
1.305 | 651 | 1 |
1.310 | 8561 | 2 |
Last trade - 11.45am 28/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online